ENDRA Life Sciences

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$211
$0
$0
Gross Profit
-32
-45
EBITDA
-1,268
-990
-4,250
-1,497
EBIT
-1,301
-1,036
-4,296
-1,551
Net Income
-1,225
-1,036
-4,149
-2,354
Net Change In Cash
0
211
0
0
Free Cash Flow
-1,113
-1,310
-1,515
-1,657
Cash
1,808
2,064
3,229
4,745
Basic Shares
717
557
534
1,122

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-206
-275
-234
-224
EBITDA
-11,301
-10,397
-12,944
-11,006
EBIT
-11,507
-10,672
-13,179
-11,231
Net Income
-11,507
-10,060
-13,200
-11,189
Net Change In Cash
0
0
0
0
Free Cash Flow
-7,416
-9,582
-12,971
-11,167
Cash
3,229
2,833
4,889
9,461
Basic Shares
1,122
1,707
1,930
2,046

Earnings Calls

Quarter EPS
2025-06-30
-$1.71
2025-03-31
-$7.72
2024-12-31
$25.20
2024-09-30
-$9.54